BIRMINGHAM, Ala. (The Street) The Food and Drug Administration has authorized the emergency use of peramivir, an experimental antiviral drug, to treat swine flu, also known as H1N1 influenza. The drug is being developed by BioCryst (BCRX Quote) LINK
If only they would do this for Ampligen and Hemispherx Biopharma.
Subscribe to:
Post Comments (Atom)

My man .. what do you think abt NUBL. target price is .25.
ReplyDeleteI'm not in NUBL but it does look good. It should certainly go beyond its current price and it's probably a good bet you'll see it 0.05 to 0.12 cent range by the end of the year. I put my money on GuangZhou Global Telecom (GZGT)betting on the better Chinese economy.
ReplyDelete